Stock listing

Curatis Holding Ag

Selected listing: A40BDL · LS · EUR · DE

Curatis Holding Ag (Lang & Schwarz: A40BDL), Health Technology. Latest release Sep 21, 2026: Strongest Half-Year in Curatis’s History — Revenue up 51%…

A40BDL:LSEURDEUpdated October 2, 2026

Ticker: Lang & Schwarz: A40BDL
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Lang & Schwarz
Currency: EUR

About Curatis Holding Ag

The company operates in the healthcare sector, focusing on innovative solutions. Curatis aims to improve patient outcomes through its specialized products and services.

Latest news from Curatis Holding Ag

Strongest Half-Year in Curatis’s History — Revenue up 51% and Significant Progress on Corticorelin (C-PTBE-01)

September 21, 2026

Curatis Increases Revenue Growth Guidance for 2026

June 11, 2026

Annual General Meeting of Curatis Holding AG approved all proposals of the Board of Directors

May 22, 2026

Curatis Holding AG announces CHF 3.0 million private placement with strategic investor

May 22, 2026

Curatis: Double-Digit Revenue Growth in 2025 and Major Milestones for Corticorelin Achieved

March 24, 2026

All Curatis Holding Ag news →

Research Curatis Holding Ag

Curatis Holding Ag company profile

View the public company page for Curatis Holding Ag on 6ix.

Curatis Holding Ag news

Read company news and market updates connected to Curatis Holding Ag.

Curatis Holding Ag investor events

Find investor webinars, events, and replay context for Curatis Holding Ag.